Publications: 80 peer-reviewed publications

For Research Use Only.  Not for use in diagnostic procedures.

Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands, published by International Journal of Molecular Sciences, May 2023

National and Kapodistrian University of Athens, Athens, Greece published by Cancers, March 2023

University Medical Center Hamburg-Eppendorf, Hamburg, Germany, published by Cancer Cell International, March 2023

Barts Cancer Institute, Queen Mary University of London, London, United Kingdom, January 2023

University Hospital Hamburg-Eppendorf, Hamburg, Germany, published by Biomedicines, November 2022

Medical University of Vienna, Vienna, Austria, published by Clinical Chemistry and Laboratory Medicine, November 2022

University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA, published by Cancer Research Communications, November 2022

University Hospital Hamburg-Eppendorf, Hamburg, Germany, published by Cancers, September 2022

University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA , published by Cancers, October 2022

Universidade de Vigo, Vigo, Spain and the Galicia Sur Health Research Institute , Spain, published by Genomics, October 2022

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, published by Breast Cancer Research and Treatment, September 2022

Institute of Head and Neck Studies and Education, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom, published by Head and Neck, July 2022

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Institute, University of Rochester, Rochester, New York and ANGLE Europe Limited, Surrey Research Park, Guildford, Surrey, United Kingdom, published by Obstetrics & Gynecology, September 2022

Edith Cowan University, Perth, Australia, published by Journal of Cancer Research and Clinical Oncology, July 2022

University Hospital and Medical Faculty, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany, published by Cytometry, June 2022

National and Kapodistrian University of Athens, Greece, published by Cancers, June 2022

National and Kapodistrian University of Athens, Greece, published by Clinical Epigenetics, May 2022

Molecular Oncology Laboratory at the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland, published by Nature, June 2022

School of Medical and Health Sciences, Edith Cowan University, Perth, Australia, published by Translational Lung Cancer Research, May 2022

School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK, published by BMC Cancer, April 2022

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, published by Clinical Chemistry, March 2022

Molecular Oncology Laboratory, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland, published by Cancer Research, February 2022

University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Institute, Baltimore, Maryland, USA, published by Breast Cancer Research, February 2022

Universidad Autonoma de Madrid, Madrid, Spain, published by Frontiers in Pharmacology, January 2022

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, published by Scientific Reports, January 2022

Edith Cowan University, Perth, Australia, published by Cancers, December 2021

University of Southern California Norris Cancer Center, Los Angeles, United States, published by Annals of Surgical Oncology, January 2022

National and Kapodistrian University of Athens, Greece, published by Cancers, November 2021

Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Austria, published by Journal of Personalized Medicine, November 2021

Institute of Head and Neck Studies and Education, Institute of Cancer and Genomic Sciences, University of Birmingham, UK, published by Cancers, November 2021

Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), Santiago de Compostela, Spain published by Molecular Oncology, August 2021

Department of Urology, Medical University Innsbruck, Innsbruck, Austria published by Biomedicines, August 2021

UCL Cancer Institute, University College London, London, UK, published by Endocrine-Related Cancer, July 2021

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia published by Radiology and Oncology, July 2021

University Medical Center Hamburg-Eppendorf, Hamburg, Germany published by International Journal of Molecular Sciences, June 2021

National and Kapodistrian University of Athens, Greece published by Cancers, May 2021

Washington University School of Medicine, St. Louis, Missouri, United States published by PLoS ONE, May 2021

Department of Gastro-Intestinal Surgery, University Hospital Ghent, Belgium published by PLoS ONE, May 2021

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy published by ESMO Open / Cancer Horizons, March 2021

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany published by Cancers, February 2021

National and Kapodistrian University of Athens, Greece published by Nature Scientific Reports, January 2021

The CANCER-ID Consortium published by Clinical Chemistry, January 2021

London Regional Cancer Program and Flow Cytometry, London Health Sciences Centre; Departments of Anatomy & Cell Biology and Oncology, Western University; and Lawson Health Research Institute, London, Ontario, Canada published by Clinical & Experimental Metastasis, January 2021

Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, United States published by PLOS ONE, October 2020

Department of Bioscience, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Switzerland published by Cell Reports, September 2020

Laboratory of Translational Oncology, School of Medicine, University of Crete, Greece published by Cancers, June 2020

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, United States published by International Journal of Molecular Sciences, July 2020

Liquid Biopsy Analysis Unit, Health Research Institute of Santiago, Spain published by Cells, February 2020

Keck School of Medicine, University of Southern California, United States published by International Journal of Cancer, February 2020

University of Athens, Greece published by Nature Scientific Reports, April 2020

University Medical Center Hamburg-Eppendorf, Hamburg, Germany published by Journal of Neuro-Oncology, February 2020

Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy published by International Journal of Molecular Sciences, February 2020

University Medical Center Hamburg-Eppendorf, Hamburg, Germany published by Cancers, February 2020

Edith Cowan University, Perth, Australia published by British Journal of Cancer, February 2020

University Medical Center Hamburg-Eppendorf, Hamburg, Germany published by Cancers, October 2019

Institute of Head and Neck Studies and Institute of Immunology and Immunotherapy, University of Birmingham, UK published by Cancers, August 2019

Barts Cancer Institute, Queen Mary University of London, UK published by Journal of Urology, September 2019

Medical University of Vienna, Austria published by Cells, August 2019

University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany published by Cancers, June 2019

Department of Oncology, Hematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany published by Cancers, June 2019

Biomarker Research Program, Houston Methodist Research Institute in conjunction with the Center for Precision Health, University of Texas and MD Anderson Cancer Center, Houston, United States published by International Journal of Molecular Sciences, April 2019

The University of Texas MD Anderson Cancer Center, Houston, United States published by Nature, March 2019

Disseminated Cancer Cell Network (DCCNet) at the University Hospital and Medical Faculty of the Heinrich-Heine University of Duesseldorf, Duesseldorf, Germany published by Clinical Chemistry, February 2019

Cancer Metastasis Laboratory, University of Basel and collaborators published by Nature, February 2019

Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany published by International Journal of Cancer, January 2019

Cancer Metastasis Laboratory, University of Basel and collaborators published by Cell, January 2019

Cancer Metastasis Laboratory, University of Basel, Switzerland published by Breast Cancer Research, November 2018

Cancer Metastasis Laboratory, University of Basel and collaborators published by British Journal of Cancer, August 2018

ANGLE plc published by Cytometry Part A, Journal of Quantitative Cell Science, July 2018

Department of Cellular Pathology, Musgrove Park Hospital, Taunton UK published by the Journal of Clinical Pathology, March 2018

University of Southern California Norris Comprehensive Cancer Center published by Oncotarget, January 2018

University Medical Centre Hamburg-Eppendorf, Medical University of Graz and Stockholm University published by Clinical Chemistry, January 2018

Medical University of Vienna published by Oncotarget, November 2017

Clinic for Urology, University Hospital Muenster, Muenster, Germany published by Oncotarget, September 2017

Heinrich Heine University of Dusseldorf published by International Journal of Molecular Sciences, August 2017

Barts Cancer Institute published by Clinical Cancer Research, June 2017

University Medical Centre Hamburg-Eppendorf (UKE) published by Clinical Chemistry, September 2016

University Medical Centre Hamburg-Eppendorf (UKE) published by International Journal of Cancer, January 2016

Cancer Research UK Manchester Institute and Christie NHS Foundation Trust, Manchester UK published by Royal Society of Chemistry Analyst publication, November 2015

Barts Cancer Institute, published by PLOS ONE on 23 September 2015

Posters: 45 publicly available posters

For Research Use Only.  Not for use in diagnostic procedures.

ANGLE Europe Limited as presented at the American Association for Cancer Research, Florida, USA, April 2023

ANGLE plc as presented at the European Association for Cancer Research, Florence, Italy, March 2023

ANGLE Europe Limited as presented at the San Antonio Breast Cancer Symposium, Texas, USA, December 2022

MD Anderson Cancer Center as presented at the San Antonio Breast Cancer Symposium, Texas, USA, December 2022

ANGLE Europe Limited as presented at the 4th Annual International Society of Liquid Biopsy Congress in Miami, Florida, USA October 2022

ANGLE Onc-ADaPT Labs as presented at the 100th American Society of Clinical Pathology (ASCP) Meeting in Chicago, Illinois, USA September 2022

Trinity College Dublin as presented at EACR Liquid Biopsies Conference, May 2022

ANGLE plc, as presented at AACR, April 2022

ANGLE plc and University of Rochester Medical Center, Wilmot Cancer Institute as presented at SGO, March 2020

ANGLE plc and University of Rochester Medical Center, Wilmot Cancer Institute as presented at SGO, March 2018

Barts Cancer Institute, Queen Mary University of London, UK as presented at NCRI Festival 8-12 November 2021

Medical University of Vienna, Austria as presented at the Fifth Advances in Circulating Tumour Cells (ACTC) Meeting in Kalamata, Greece, September 2021

Medical University of Vienna, Austria as presented at the Fifth Advances in Circulating Tumour Cells (ACTC) Meeting in Kalamata, Greece, September 2021

Medical University of Vienna, Austria as presented at the Fifth Advances in Circulating Tumour Cells (ACTC) Meeting in Kalamata, Greece, September 2021

ANGLE plc as presented at AACR 2021 Virtual Meeting, April / May 2021

ANGLE plc as presented at AACR 2021 Virtual Meeting, April / May 2021

University of Athens, Greece as presented at AACR 2019 in Atlanta, United States, March / April 2019

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy as presented at AACR 2019 in Atlanta, United States, March / April 2019

Northwestern University, Chicago, United States as presented at AACR 2019 in Atlanta, United States, March / April 2019

University of Athens, Greece as presented at AACR 2019 in Atlanta, United States, March / April 2019

ANGLE plc as presented at AACR 2019 in Atlanta, United States, March / April 2019

ANGLE plc as presented at AACR 2019 in Atlanta, United States, March / April 2019

ANGLE plc as presented at the 6th Annual Advances in Prenatal Molecular Diagnostics conference in Cambridge, MA, October 2018

ANGLE plc and QIAGEN GmbH as presented at the 11th International Symposium on Minimal Residual Cancer in Montpellier, France, May 2018 (ISMRC 2018)

Robert H Lurie Comprehensive Cancer Center and the Feinberg School of Medicine, Northwestern University, Chicago as presented at AACR 2018 in Chicago, April 2018

Bayer AG, Pharmaceutical Division as presented at AACR 2018 in Chicago, April 2018

University of Southern California Norris Comprehensive Cancer Center as presented at the San Antonio Breast Cancer Symposium in Texas, December 2017

ANGLE plc as presented at the AACC Emerging Clinical & Laboratory Diagnostics in the Healthcare Ecosystem (ECLD) conference in San Diego, November 2017

Universityclinic Tuebingen, Germany as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017

Heinrich-Heine University Duesseldorf, Germany as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017

Barts Cancer Institute, Queen Mary University of London as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017

VyCAP B.V. as presented at the Third International Advances in Circulating Tumour Cells (ACTC) Symposium in Rhodes, October 2017

MD Anderson as presented at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, August 2016 (AACC 2016)

Fraunhofer ITEM as presented at the 24th Biennial Congress of the European Association for Cancer Research, July 2016 (EACR 2016)

ANGLE Research & Development Laboratory as presented at the 24th Biennial Congress of the European Association for Cancer Research, July 2016 (EACR 2016)

Cancer Research UK Manchester Institute as presented at the American Association for Cancer Research Annual Meeting 2016, April 2016

Heinrich-Heine University, Düsseldorf, Germany as presented at the 10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, March 2016

Cancer Research UK Manchester Institute, as presented at the 10th ISMRC International Symposium on Minimal Residual

Cancer Research UK Manchester Institute, as presented at the 10th ISMRC International Symposium on Minimal Residual

Medical University of Vienna, as presented at 18th ECCO – 40th ESMO European Cancer Congress September 2015

Barts Cancer Institute, as presented at a symposium hosted by the British Association for Cancer Research and Cancer Research UK on 11 June 2015

Medical University of Vienna, as presented at the AACR conference April 2015

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, as presented at the AACR conference April 2015

CRUK – Manchester, as presented at NCRI conference November 2014

The University Medical Center Hamburg-Eppendorf (UKE), as presented at ACTC Conference, October 2014

Articles

Published by SHARES spotlight August 2022

Published by SHARES spotlight May 2021

Andrew Newland, CEO ANGLE plc, published by European Biopharmaceutical Review, January 2021

Whitepapers

For Research Use Only.  Not for use in diagnostic procedures.

Parsortix® Cell Separation System Small Volume Capabilities

Presentations

Presentation to the American Association for Cancer Research conference September 7 – October 21, 2021

Presentation to the Sixth International Molecular Diagnostics Europe conference on 24 May 2018